These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3221466)

  • 21. [Therapeutic effects of Nootropyl].
    Houillon P; Kitenge A; Jouannigot R; Lullien L
    Ann Med Psychol (Paris); 1980; 138(7):869-76. PubMed ID: 7458110
    [No Abstract]   [Full Text] [Related]  

  • 22. [Management of neuroleptic side-effects with piracetam (author's transl)].
    Sikora J; Kabes J; Pisvejc J
    Cesk Psychiatr; 1981 Apr; 77(2):137-42. PubMed ID: 6114800
    [No Abstract]   [Full Text] [Related]  

  • 23. [Experience using nootropil in patients with chronic ischemic heart disease].
    Shubina TI; Zaĭtsev VP
    Klin Med (Mosk); 1989 May; 67(5):36-8. PubMed ID: 2671485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Piracetam: physiological disposition and mechanism of action.
    Tacconi MT; Wurtman RJ
    Adv Neurol; 1986; 43():675-85. PubMed ID: 3946121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Piracetam plus lecithin trials in senile dementia of the Alzheimer type.
    Samorajski T; Vroulis GA; Smith RC
    Ann N Y Acad Sci; 1985; 444():478-81. PubMed ID: 3893273
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pilot study of 2-pyrrolidon-acetamid (generic name: piracetam) (author's transl)].
    Tacke B; Freistein H; Kempf H; Windheuser A
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Mar; 8(2):82-9. PubMed ID: 788004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Letter: Piracetam and pyrithioxine.
    Machanick S
    S Afr Med J; 1975 Aug; 49(37):1503. PubMed ID: 1099696
    [No Abstract]   [Full Text] [Related]  

  • 28. Piracetam in chronic brain failure.
    Lloyd-Evans S; Brocklehurst JC; Palmer MK
    Curr Med Res Opin; 1979; 6(5):351-7. PubMed ID: 540525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haemorheological pattern in initial mental deterioration: results of a long-term study using piracetam and pentoxifylline.
    Parnetti L; Ciuffetti G; Mercuri M; Senin U
    Arch Gerontol Geriatr; 1985 Jul; 4(2):141-55. PubMed ID: 3899033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy of piracetam in vertigo. A double-blind study in patients with vertigo of central origin.
    Oosterveld WJ
    Arzneimittelforschung; 1980; 30(11):1947-9. PubMed ID: 7006617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Certain principles for differential utilization of metabolic treatment preparations in the complex therapy of mental disorders].
    Avrutskiĭ GIa; Laskova NB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(8):1077-83. PubMed ID: 484144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Use of piracetam in the treatment of cranial injuries. Observations on 903 cases].
    Cicerchia G; Santucci R; Palmieri M
    Clin Ter; 1985 Sep; 114(6):481-7. PubMed ID: 3905223
    [No Abstract]   [Full Text] [Related]  

  • 33. [Current antidementive therapy].
    Perneczky R; Kurz A
    MMW Fortschr Med; 2004 May; 146 Spec No 2():53-6. PubMed ID: 15376702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of piracetam, a nootropic agent, on experimental gastric ulcers in rat.
    Goel RK; Chakravarty M; Abbas WR; Singh KP; Bhattacharya SK
    Indian J Exp Biol; 1990 Apr; 28(4):337-40. PubMed ID: 2351418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neurophysiological analysis of the correction by nootropic substances of disorders in the bioelectric activity of the brain in animals during chronic administration of ethanol].
    Krapivin SV; Bogdanov NN; Voronin KE
    Biull Eksp Biol Med; 1988 Jul; 106(7):52-6. PubMed ID: 3401579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of acoustic traumatism with injectable vincamine. Random double blind clinical trial with a complementary comparative element (author's transl)].
    Hennebert D; De Heyn G
    Rev Med Brux; 1982 Jan; 3(1):37-43. PubMed ID: 7038815
    [No Abstract]   [Full Text] [Related]  

  • 37. [Use of preparations from the nootropic group for treating memory disorders in chronic alcoholism].
    Shabanov PD; Grinenko AIa; Kalishevich SIu
    Klin Med (Mosk); 1988 Sep; 66(9):114-6. PubMed ID: 3204950
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cognitive function in alcoholics in a double-blind study of piracetam].
    Buranji I; Skocilić Z; Kozarić-Kovacić D
    Lijec Vjesn; 1990; 112(3-4):111-4. PubMed ID: 2204773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical trial of the use of the combination of piracetam and dihydroergocristine in vertigo from different causes].
    Ordosgoitia H; Castro C; Carbayeda M; Labella T
    An Otorrinolaringol Ibero Am; 1989; 16(3):271-9. PubMed ID: 2502041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of nootropic agents on the brain bioelectrical activity and on the indices of neuromediator metabolism in the acute period of severe craniocerebral trauma].
    Madorskiĭ SV; Potapov AA; Piasetskaia MV; Shapova EV; Il'icheva RF
    Zh Vopr Neirokhir Im N N Burdenko; 1989; (3):29-35. PubMed ID: 2572097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.